Jennison Associates LLC Guardant Health, Inc. Transaction History

Jennison Associates LLC

$155 Billion
Q2 2024

A detailed history of Jennison Associates LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 497,088 shares of GH stock, worth $10.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

497,088

Previous 489,657 1.52%

Holding current value

$10.6 Million

Previous $10.1 Million 42.11%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$16.07 - $31.84 $119,416 - $236,603	7,431 Added 1.52%	497,088 $14.4 Million
Q1 2024 May 02, 2024	BUY	$17.13 - $26.91 $168,062 - $264,014	9,811 Added 2.04%	489,657 $10.1 Million
Q4 2023 Feb 01, 2024	SELL	$21.58 - $29.5 $30.5 Million - $41.6 Million	-1,411,038 Reduced 74.62%	479,846 $13 Million
Q3 2023 Oct 31, 2023	BUY	$25.8 - $39.97 $10.4 Million - $16.1 Million	403,475 Added 27.13%	1,890,884 $56 Million
Q2 2023 Aug 03, 2023	BUY	$20.94 - $38.01 $31.1 Million - $56.5 Million	1,487,409 New	1,487,409 $53.2 Million
Q1 2022 May 11, 2022	SELL	$48.25 - $100.49 $8.07 Million - $16.8 Million	-167,226 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$88.71 - $120.43 $45.2 Million - $61.4 Million	-509,718 Reduced 75.3%	167,226 $16.7 Million
Q3 2021 Nov 09, 2021	SELL	$98.77 - $132.17 $807,444 - $1.08 Million	-8,175 Reduced 1.19%	676,944 $84.6 Million
Q2 2021 Aug 12, 2021	SELL	$109.77 - $165.68 $224 Million - $339 Million	-2,043,552 Reduced 74.89%	685,119 $85.1 Million
Q1 2021 May 11, 2021	SELL	$127.04 - $179.1 $35.4 Million - $49.8 Million	-278,306 Reduced 9.26%	2,728,671 $417 Million
Q4 2020 Feb 05, 2021	SELL	$99.96 - $135.93 $17 Million - $23.2 Million	-170,468 Reduced 5.36%	3,006,977 $388 Million
Q3 2020 Nov 04, 2020	SELL	$80.32 - $111.8 $12.7 Million - $17.6 Million	-157,764 Reduced 4.73%	3,177,445 $355 Million
Q2 2020 Aug 06, 2020	BUY	$60.49 - $97.5 $44.6 Million - $71.9 Million	737,024 Added 28.37%	3,335,209 $271 Million
Q1 2020 May 06, 2020	SELL	$59.04 - $88.81 $3.78 Million - $5.69 Million	-64,048 Reduced 2.41%	2,598,185 $181 Million
Q4 2019 Feb 07, 2020	SELL	$59.49 - $82.78 $42.4 Million - $59.1 Million	-713,456 Reduced 21.14%	2,662,233 $208 Million
Q3 2019 Nov 08, 2019	BUY	$62.59 - $110.3 $38.9 Million - $68.6 Million	622,154 Added 22.59%	3,375,689 $215 Million
Q2 2019 Aug 06, 2019	BUY	$63.94 - $91.11 $132 Million - $188 Million	2,068,098 Added 301.72%	2,753,535 $0
Q1 2019 May 10, 2019	SELL	$34.3 - $97.98 $5.42 Million - $15.5 Million	-157,883 Reduced 18.72%	685,437 $52.6 Million
Q4 2018 Feb 06, 2019	BUY	$29.2 - $46.1 $24.6 Million - $38.9 Million	843,320 New	843,320 $31.7 Million

Others Institutions Holding GH

# of Institutions

332

Shares Held

112M

Call Options Held

680K

Put Options Held

1.66M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.19B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Guardant Health, Inc. Transaction History